BONESUPPORT Reports 3Q18 Revenue of SEK 14.2MM, -56.4% vs. 3Q17
BONESUPPORT continues transition of U.S distribution, posts 3Q18 revenue of SEK 14.2MM (USD $1.7MM), -56.4% vs. 3Q17....
Nov 14, 2018,
BONESUPPORT Reports 3Q18 Revenue of SEK 14.2MM, -56.4% vs. 3Q17
Medacta Acquires Balgrist CARD
Medacta invests in personalized medicine by acquiring start-up Balgrist CARD....
Nov 14, 2018, Julie Vetalice
Arthrex Collaborates with CellRight Technologies on Distribution
CellRight Technologies, a Tissue Regenix company, entered into an agreement granting Arthrex distribution rights to its BioRinse bone portfolio in Europe....
Nov 13, 2018, Julie Vetalice
Implanet Enters Distribution Agreement with KICO Knee
Implanet partnered with KICO Knee Innovation Company for distribution of the MADISON primary total knee....
Nov 13, 2018, Julie Vetalice
CartiHeal Enrolls First Agili-C Patient on East Coast
CartiHeal announced successful enrollment of the first patient in the Agili-C IDE pivotal study on the East Coast....
Nov 13, 2018, Julie Vetalice
Bio2 Gains Approval to Study Vitrium in Interbody Fusion
Bio2 Technologies received FDAÂ approval to enroll subjects in an IDE clinical study of Vitrium bioactive glass as a cervical interbody...
Nov 13, 2018, Julie Vetalice
Treace Medical Kicks Off Postmarket Study of Bunion Correction
Treace Medical Concepts enrolled the first patient in the ALIGN3D postmarket study of Lapiplasty® 3D Bunion Correction....
Nov 13, 2018, Julie Vetalice
Alphatec Spine Reports 3Q18 Revenue of $23MM, -0.4% vs. 3Q17
Alphatec Spine reports 3Q18 revenue of US $23MM, -0.4% vs. 3Q17....
Nov 13, 2018, Mike Evers
Globus Medical Reports 3Q18 Revenue of $169.2MM, +11.5% vs. 3Q17
Globus Medical continues double-digit growth trend, posts 3Q18 revenue of $169.2MM, +11.5% vs. 3Q17...
Nov 13, 2018, Mike Evers
K2M Reports 3Q18 Revenue of $71.4MM, +13.9% vs. 3Q17
K2M reports final quarterly results before acquisition by Stryker, posts 3Q18 revenue of $71.4MM, +13.9% vs. 3Q17....
Nov 13, 2018, Mike Evers
Loading new posts...
No more posts
